• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Shot fired across the IS bow on Friday

hey southern boy-there are no large teaching hospitals in the south, with a couple of exceptions. So you wouldn't know out here in the west, no interactions possible, no more paying off people to be "speakers", no more food,grants,etc all your left with is Icue and shown the door with 10 year old studies. please stop the bs, pretend with your boss-not here. Back east I hear it is worse. we have already been told that we will probably out the door in the fall.